FindTrial
Sign In

Results after the surgical therapy of the symptomatic prostate adenoma in unselected patients with two laser systems

Results after the surgical therapy of the symptomatic prostate adenoma in unselected patients with two laser systems

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024736
Enrollment
500
Registered
2021-03-16
Start date
2021-04-09
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N40

Interventions

Group 1: Patients who have undergone greenlight laser vaporization of the prostate or holmium laser enucleation for the treatment of symptomatic benign prostatic hyperplasia are asked once about the o

Sponsors

Krankenhaus Reinbek St. Adolf Stift
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Indication for transurethral intervention for the treatment of symptomatic prostatic hyperplasia according to the DGU and EAU guidelines.

Exclusion criteria

Exclusion criteria: Presence of a relevant prostate cancer.

Design outcomes

Primary

MeasureTime frame
Morbidity and quality of results after transurethral laser-assisted therapy of symptomatic prostatic hyperplasia.—

Secondary

MeasureTime frame
Identification of risk factors for an unfavorable post-interventional outcome.—

Countries

Germany

Contacts

Public ContactClaus Brunken

Krankenhaus Reinbek St. Adolf Stift

claus.brunken@krankenhaus-reinbek.de040 7280 3300

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026